Výsledky vyhledávání - "Nemunaitis John"

Akademický článek

Smart exosomes enhance PDAC targeted therapy

Autor: Creeden, Justin F., Sevier, Jonathan, Zhang, Jian-Ting, Lapitsky, Yakov, Brunicardi, F. Charles, Jin, Ge, Nemunaitis, John, Liu, Jing-Yuan, Kalinoski, Andrea, Rao, Donald, Liu, Shi-He

Publikováno v: In Journal of Controlled Release April 2024 368:413-429

Zobrazit plný text záznamu

Akademický článek

First-in-man application of a novel therapeutic cancer vaccine formulation with the capacity to induce multi-functional T cell responses in ovarian, breast and prostate cancer patients

Autor: Berinstein Neil L, Karkada Mohan, Morse Michael A, Nemunaitis John J, Chatta Gurkamal, Kaufman Howard, Odunsi Kunle, Nigam Rita, Sammatur Leeladhar, MacDonald Lisa D, Weir Genevieve M, Stanford Marianne M, Mansour Marc

Publikováno v: Journal of Translational Medicine, Vol 10, Iss 1, p 156 (2012)

Abstract Background DepoVaxTM is a novel non-emulsion depot-forming vaccine platform with the capacity to significantly enhance the immunogenicity of peptide cancer antigens. Naturally processed HLA-A2 restricted peptides presented by breast, ovarian

Externí odkaz: https://doaj.org/article/10cd399e2e724a228b6e2bd521cd9b3a

Zobrazit plný text záznamu

Akademický článek

Phase II assessment of talabostat and cisplatin in second-line stage IV melanoma

Autor: Anthony Stephen P, Stephenson Joe, Senzer Neil N, Cunningham C Casey, Eager Robert M, O'Day Steven J, Frenette Gary, Pavlick Anna C, Jones Barry, Uprichard Margaret, Nemunaitis John

Publikováno v: BMC Cancer, Vol 9, Iss 1, p 263 (2009)

Abstract Background Metastatic melanoma is an incurable disease with an average survival of less than one year. Talabostat is a novel dipeptidyl peptidase inhibitor with immunostimulatory properties. Methods This phase II, open label, single arm stud

Externí odkaz: https://doaj.org/article/33f45ad947244325bf65b471f867c032

Zobrazit plný text záznamu